Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$46.84 - $59.75 $3,606 - $4,600
-77 Closed
0 $0
Q4 2021

Jan 14, 2022

SELL
$47.19 - $62.68 $14,251 - $18,929
-302 Reduced 79.68%
77 $4,000
Q4 2020

Feb 17, 2021

BUY
$43.41 - $56.51 $16,452 - $21,417
379 New
379 $21,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Freedman Financial Associates, Inc. Portfolio

Follow Freedman Financial Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Freedman Financial Associates, Inc. with notifications on news.